foxo4-dri peptide senolytic animal study FOX04-DRI - Apollo Peptide Sciences
FOX04 DRI Apollo Peptide Sciences foxo4 dri senolytic peptide animal study Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell Development of a novel senolytic FOXO4 DRI 10mg Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27


